Global Cord Blood
CORBF
#8844
Rank
โ‚น12.94 B
Marketcap
โ‚น96.68
Share price
0.00%
Change (1 day)
-3.73%
Change (1 year)
Categories

Revenue for Global Cord Blood (CORBF)

Revenue in 2022 (TTM): โ‚น14.50 Billion

According to Global Cord Blood's latest financial reports the company's current revenue (TTM ) is โ‚น17.87 Billion. In 2021 the company made a revenue of โ‚น14.39 Billion an increase over the revenue in the year 2020 that were of โ‚น12.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Global Cord Blood from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น14.50 B0.78%
2021 โ‚น14.39 B16.64%
2020 โ‚น12.34 B2.36%
2019 โ‚น12.05 B18.66%
2018 โ‚น10.16 B17.59%
2017 โ‚น8.64 B18.76%
2016 โ‚น7.27 B3.09%
2015 โ‚น7.05 B10.29%
2014 โ‚น6.39 B14.5%
2013 โ‚น5.58 B30.21%
2012 โ‚น4.29 B38.63%
2011 โ‚น3.09 B46.91%
2010 โ‚น2.10 B62.49%
2009 โ‚น1.29 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
RadNet
RDNT
โ‚น181.35 B 914.48%๐Ÿ‡บ๐Ÿ‡ธ USA
National Healthcare
NHC
โ‚น138.17 B 672.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น65.29 B 265.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cryo-Cell
CCEL
โ‚น2.94 B-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA